Table 2.
Levels of adherence to pegylated IFN and ribavirin treatment among 188 patients with chronic hepatitis C virus infection.
| No. of patients, by pegylated IFN adherence |
||||||
|---|---|---|---|---|---|---|
| Variable | <80% | 80%–84% | 85%–89% | 90%–99% | ⩾100% | Total |
| Ribavirin adherence | ||||||
| <80% | 2 | 0 | 0 | 2 | 7 | 11 |
| 80%–84% | 0 | 5 | 0 | 0 | 4 | 9 |
| 85%–89% | 0 | 0 | 6 | 0 | 0 | 6 |
| 90%–99% | 0 | 0 | 0 | 28 | 4 | 32 |
| ⩾100% | 0 | 0 | 0 | 5 | 125 | 130 |
| Total | 2 | 5 | 6 | 35 | 140 | 188 |
NOTE. Adherence to one medication corresponded in most cases to a similar level of adherence to the other medication. Thirteen patients (7%) had ⩾90% adherence to pegylated IFN but <85% adherence to ribavirin.